开拓药业-B(09939)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09939 开拓药业-B

已收盘 06-12 16:08:19

2.400

+0.040

+1.69%

最高2.480	最低2.350	成交量41.55万
今开2.360	昨收2.360	日振幅5.51%
总市值11.98亿	流通市值11.98亿	总股本4.99亿
成交额100.39万	换手率0.08%	流通股本4.99亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09939","market":"HK","secType":"STK","nameCN":"开拓药业-B","latestPrice":2.4,"timestamp":1781251699813,"preClose":2.36,"halted":0,"volume":415500,"delay":0,"changeRate":0.0169491525423729,"floatShares":499000000,"shares":499000000,"eps":-0.5155796194729791,"marketStatus":"已收盘","change":0.04,"latestTime":"06-12 16:08:19","open":2.36,"high":2.48,"low":2.35,"amount":1003890,"amplitude":0.055085,"askPrice":2.41,"askSize":1000,"bidPrice":2.4,"bidSize":500,"shortable":0,"etf":0,"ttmEps":-0.5145297007592676,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781487000000},"marketStatusCode":5,"adr":0,"listingDate":1590076800000,"exchange":"SEHK","adjPreClose":2.36,"openAndCloseTimeList":[[1781227800000,1781236800000],[1781240400000,1781251200000]],"volumeRatio":0.542712,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09939","defaultTab":"news","newsList":[{"id":"2642354252","title":"【券商聚焦】中信建投证券首予劲方医药-B(02595)“买入”评级 指公司RAS靶向矩阵布局持续推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2642354252","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642354252?lang=zh_cn&edition=full","pubTime":"2026-06-12 13:55","pubTimestamp":1781243717,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券发布研报指，劲方医药-B 两项研究成果入选2026年ASCO年会，其中GFH375在KRAS G12D突变胆管癌及结直肠癌后线患者中显示初步疗效，GFS202A I期数据支持GDF15/IL-6双靶向改善肿瘤恶病质的可行性。公司RAS靶向矩阵与恶病质差异化布局持续推进，首次覆盖给予“买入”评级，未给出目标价。安全性方面，GFH375在合计61例患者中≥3级TRAE发生率31.1%，TRAE导致治疗终止比例3.3%，未观察到新的安全信号。首次覆盖，给予“买入”评级。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983634","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","09939","02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642254781","title":"医药板块集体回升 科伦博泰生物(06990)涨7.20%、荣昌生物(09995)涨6.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2642254781","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642254781?lang=zh_cn&edition=full","pubTime":"2026-06-12 13:30","pubTimestamp":1781242214,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股医药板块集体回升，科伦博泰生物 涨7.20%，荣昌生物涨6.53%，康诺亚-B涨5.58%，复宏汉霖涨5.36%，康方生物涨5.07%，君实生物涨4.61%，药明合联涨4.06%，诺诚健华涨3.96%。英伟达同时为 Abridge 投资方，新模型基于英伟达开放模型套件 Nemotron 训练，Abridge 将采用去标识化临床数据进行定制优化，预计 2026 年晚些时候上线。东莞证券研报认为，受行业合规整顿以及消费疲软等因素影响，2025年医药生物行业整体归母净利润同比有所下滑。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983673","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000306685.HKD","LU2488822045.USD","HK0000165453.HKD","06990","LU0348784397.USD","688331","HK0000320264.USD","LU2476274720.SGD","01877","LU2476274308.USD","LU2148510915.USD","LU1064131003.USD","HK0000320223.HKD","LU0348827113.USD","BK1574","LU1064130708.USD","LU2399975544.HKD","LU0348766576.USD","LU0417516902.SGD","SG9999014674.SGD","09995","BK1583","LU0417516738.SGD","IE00BPRC5H50.USD","BK1161","LU0540923850.HKD","LU1961090484.USD","LU0561508036.HKD","LU1720050803.USD","LU0348767384.USD","LU1794554557.SGD","BK0239","LU0348825331.USD","09926","BK1141","LU2328871848.SGD","LU0348735423.USD","LU0348783233.USD","159938","09939","09969","BK1587","HK0000306701.USD","02162","02696","BK1515","LU0417516571.SGD","02268","LU1969619763.USD","LU0634319403.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642281453","title":"金活医药集团(01110)：金辰医药与东莞市中医院就两款产品的研发订立谅解备忘录","url":"https://stock-news.laohu8.com/highlight/detail?id=2642281453","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642281453?lang=zh_cn&edition=full","pubTime":"2026-06-11 20:02","pubTimestamp":1781179376,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金活医药集团(01110)发布公告，于2026年6月11日，公司的关连人士金辰医药有限公司(金辰)已与广州中医药大学东莞医院(东莞市中医院)就产品“紫珠叶洗剂”及“加味天麻健脑方”的研发订立谅解备忘录。各方拟就产品“紫珠叶洗剂”及“加味天麻健脑方”的临床研究、监管注册及商业化开展合作。于2026年6月11日，公司关连人士金辰已与公司订立谅解备忘录，据此，金辰拟委任公司及╱或其全资附属公司为产品“紫珠叶洗剂”及“加味天麻健脑方”的唯一及独家分销商。建议分销将涵盖产品“紫珠叶洗剂”及“加味天麻健脑方”于中国香港、中国内地及跨境电子商务渠道的分销。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453333.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1515","BK1161","01110","09939","BK1197","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642940792","title":"6月11日首药控股涨8.48%，鹏华医药科技股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642940792","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642940792?lang=zh_cn&edition=full","pubTime":"2026-06-11 16:25","pubTimestamp":1781166322,"startTime":"0","endTime":"0","summary":"证券之星消息，6月11日首药控股涨8.48%，收盘报34.42元，换手率3.71%，成交量2.37万手，成交额7785.23万元。重仓首药控股的前十大公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共10家，其中持有数量最多的公募基金为鹏华基金的鹏华医药科技股票A。鹏华医药科技股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061100025337.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK1515","BK1161","09939","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642403672","title":"楚天科技：目前专注于医药领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2642403672","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642403672?lang=zh_cn&edition=full","pubTime":"2026-06-11 11:30","pubTimestamp":1781148638,"startTime":"0","endTime":"0","summary":"证券之星消息，楚天科技(300358)06月10日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，公司旗下楚天净邦从事洁净室系统工程业务，请问近年来该板块业务拓展及订单落地成效如何？除医药领域外，公司是否有计划将洁净室业务向半导体、微电子、新能源等蓝海领域延伸布局？如有，目前处于何种阶段？谢谢！楚天科技回复：您好！目前专注于医药领域，谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061100014621.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09939","300358","BK0077","BK0061","BK0028","BK1161","BK1515","BK0251","BK1574","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642470626","title":"恒瑞医药三款新药获批临床，创新研发再添新进展｜医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2642470626","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642470626?lang=zh_cn&edition=full","pubTime":"2026-06-11 09:31","pubTimestamp":1781141460,"startTime":"0","endTime":"0","summary":"截至6月10日收盘，市场全天震荡调整，沪深两市成交额2.62万亿元。医药ETF（512120）上涨1.53%，港股通生物科技ETF（159102）上涨1.40%。相关个股中，恒瑞医药上涨1.36%、药明康德上涨3.81%、片仔癀上涨0.46%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606113767626750.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606113767626750.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1064130708.USD","LU1997245094.SGD","BK0239","LU2289578879.USD","LU1820825898.SGD","LU2097828805.USD","LU2580892789.USD","BK0188","LU1997245177.USD","BK1161","01276","LU0359201612.USD","LU2495084118.USD","BK0183","LU2097828557.USD","LU1328615791.USD","BK1191","LU1023057109.AUD","LU1580142542.USD","600276","LU2097828474.EUR","LU1064131003.USD","LU2543165471.USD","LU0405327494.USD","LU2097828631.EUR","LU1997244956.HKD","09939","BK1515","LU1146622755.USD","BK0196","BK1574","LU0405327148.USD","BK0028","BK0060","LU1969619763.USD","LU2328871848.SGD","BK0012","LU2097828714.EUR","LU0359201885.HKD","LU0359202008.SGD","LU2580892862.HKD","LU1781817850.SGD","LU2488822045.USD","LU2148510915.USD","LU1655091616.SGD","LU1255011170.USD","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642428491","title":"医药板块逆势走强，基本面有望持续改善，关注港股通创新药ETF易方达（159316）配置价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2642428491","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642428491?lang=zh_cn&edition=full","pubTime":"2026-06-10 19:04","pubTimestamp":1781089491,"startTime":"0","endTime":"0","summary":"6月10日，医药板块主要指数逆势上涨，截至收盘，恒生港股通创新药指数上涨2.0%，中证港股通医药卫生综合指数上涨1.5%，中证创新药产业指数上涨1.8%，中证生物科技主题指数上涨1.0%，沪深300医药卫生指数上涨1.6%。从估值维度看，经过这一轮调整，港股创新药板块估值已有所回落，沪深300医药指数也处于近10年历史较低分位。此外，A股创新药板块一季度收入同比增长26.4%，多家生物科技公司已实现扭亏为盈，基本面有望持续改善。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026061000035676.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","159316","BK1161","516080","09939","159938","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642443135","title":"拓新药业：新乡基地将继续承载公司原料药、医药中间体、功能食品原料产品生产、研发等核心业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2642443135","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642443135?lang=zh_cn&edition=full","pubTime":"2026-06-10 15:00","pubTimestamp":1781074851,"startTime":"0","endTime":"0","summary":"证券之星消息，拓新药业06月09日在投资者关系平台上答复投资者关心的问题。公司前次募集资金投资项目均已完成，新乡基地将继续承载公司原料药、医药中间体、功能食品原料产品生产、研发等核心业务。通过优化产能布局，实现新乡与内蒙古两大基地的协同互补，有利于提升整体核心竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061000021133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09939","BK1515","301089","BK1161","159938","BK1574","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642108254","title":"港股异动 | 先声药业(02096)午后涨超3% 近日与普祺医药就普美昔替尼凝胶订立独家推广服务协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2642108254","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642108254?lang=zh_cn&edition=full","pubTime":"2026-06-10 13:39","pubTimestamp":1781069998,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，先声药业(02096)午后涨超3%，截至发稿，涨3.03%，报9.87港元，成交额4009.82万港元。消息面上，近日，先声药业发布公告，本集团与北京普祺医药科技股份有限公司(普祺医药)就普美昔替尼凝胶订立独家推广服务协议(该协议)。根据该协议，本集团将获得普美昔替尼凝胶在中国内地、香港及澳门所有皮肤病领域适应症的独家推广权益。目前，普美昔替尼凝胶成人与青少年特应性皮炎(AD)适应症新药上市申请(NDA)已获国家药品监督管理局药品审评中心(CDE)受理。本次合作将进一步强化本集团在自身免疫领域的产品布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452434.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","BK1583","BK1161","BK4588","09939","BK1191","VXUS","BK1515","02096","BK4585","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152361325","title":"港股异动 | 生物医药股逆市活跃，华昊中天医药-B暴涨逾40%","url":"https://stock-news.laohu8.com/highlight/detail?id=1152361325","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152361325?lang=zh_cn&edition=full","pubTime":"2026-06-10 11:36","pubTimestamp":1781062600,"startTime":"0","endTime":"0","summary":"6月10日，港股生物医药股逆市活跃，$华昊中天医药-B(02563)$暴涨逾40%，$迈威生物-B(02493)$涨逾23%，$宜明昂科-B(01541)$涨逾8%，$银诺医药-B(02591)$、$泰格医药(03347)$、$科伦博泰生物(06990)$、药明康德跟涨。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1f496bb5e04e0670aba492129df4bfd4","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK4581","XBI","BK1161","BK4588","09939","VXUS","BK1515","161726","02563","BK4585","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642678416","title":"长春高新：公司全力聚焦医药创新与主业发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2642678416","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642678416?lang=zh_cn&edition=full","pubTime":"2026-06-10 08:57","pubTimestamp":1781053033,"startTime":"0","endTime":"0","summary":"证券之星消息，长春高新(000661)06月10日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司会尽快剥离房地产业务吗？长春高新回复：您好，感谢您对公司的关注，，公司全力聚焦医药创新与主业发展，同时也正推进辅业轻资产转型；同时，未来地产板块如有其他达到信息披露标准的情况，公司会按照法律法规要求履行披露义务，谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。相关 ETF","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061000007776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK0028","000661","BK0239","09939","BK0057","BK0188","BK0046","BK1515","BK0075","BK1574","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642468767","title":"港股收评：恒指跌，恒科涨；CPO概念爆发，半导体板块全天活跃，军工上涨；医药、石油石化、煤炭下跌；智谱大跌超13%，中国石油尾盘跌超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2642468767","media":"中新经纬","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642468767?lang=zh_cn&edition=full","pubTime":"2026-06-09 16:12","pubTimestamp":1780992720,"startTime":"0","endTime":"0","summary":"9日，港股主要指数走势分化，恒生科技指数盘中涨超1%。截至收盘，恒指跌0.37%，恒生科技指数涨0.29%。盘面上，硬件设备、半导体、造纸、建材、环保、军工等板块上涨。CPO概念股活跃，长飞光纤光缆盘中涨超10%。石油石化、煤炭、医药、交运、地产等板块跌幅居前；CRO、汽车电子、港口运输等概念走低。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606093765131790.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ERX","VDE","FTXL","TEKX","VGT","SOXX","SOXY","XES","DRIP","DIG","USOI","WTIU","OILT","PSI","SOXQ","DRLL","159019","IEO","VXUS","CHPY","DBC","USE","159938","02513","161032","DBE","IXC","PXE","XLE","09939","OIH","SMH","SOXL","SOXS","PXJ","USL","SMHX","OILU","OILK","GUSH","BNO","XOP","SSG","161024","HSI","FTXN","USD","CHPS","SHLD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641210764","title":"6月8日海创药业跌7.50%，鹏华医药科技股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641210764","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641210764?lang=zh_cn&edition=full","pubTime":"2026-06-08 16:43","pubTimestamp":1780908209,"startTime":"0","endTime":"0","summary":"证券之星消息，6月8日海创药业跌7.50%创60日新低，收盘报34.88元，换手率2.57%，成交量2.55万手，成交额9016.46万元。重仓海创药业的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为鹏华基金的鹏华医药科技股票A。鹏华医药科技股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060800022208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","159938","09939","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641105779","title":"医药外包概念股全线走低 金斯瑞生物科技(01548)跌7.43%、药明生物(02269)跌7.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2641105779","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641105779?lang=zh_cn&edition=full","pubTime":"2026-06-08 13:43","pubTimestamp":1780897412,"startTime":"0","endTime":"0","summary":"中邮证券表示，2026年第一季度，海外CXO行业整体呈现分化复苏格局，全球生物制药融资环境出现实质性改善，带动需求逐步回暖，但早期初创企业资金压力仍未完全缓解，不同细分赛道、不同规模企业的表现存在差异，行业结构性分化特征进一步凸显。展望2026年，海外头部CXO企业收入指引仍维持稳健小幅增长格局，叠加全球生物医药投融资逐步回暖、创新药研发需求稳步复苏，行业景气度延续上行态势，成长确定性进一步增强。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983281","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0708995583.HKD","BK1521","BK1589","LU0516422366.SGD","BK1141","LU0051755006.USD","03759","LU0516422440.USD","HK0000306685.HKD","LU0516423091.SGD","HK0000320264.USD","LU0417516902.SGD","01548","LU0572944931.SGD","01521","LU0039217434.USD","LU2039709279.SGD","09939","06821","LU0326950275.SGD","LU1720050803.USD","BK1191","159938","LU0140636845.USD","02359","LU2242644610.SGD","LU3063872942.SGD","LU0417516738.SGD","LU0320764599.SGD","LU0348735423.USD","LU1688375341.USD","LU1880383366.USD","01873","LU0359201612.USD","02269","LU0307460666.USD","LU0856984785.SGD","LU0456827905.SGD","LU0516422952.EUR","LU2045819591.USD","LU1046422090.SGD","HK0000320223.HKD","SG9999002463.SGD","LU0348766576.USD","LU0348767384.USD","BK1574","LU0588546209.SGD","03347","BK1515","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641106434","title":"上药益药医药（上海）有限公司成立","url":"https://stock-news.laohu8.com/highlight/detail?id=2641106434","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641106434?lang=zh_cn&edition=full","pubTime":"2026-06-08 13:36","pubTimestamp":1780896960,"startTime":"0","endTime":"0","summary":"企查查APP显示，近日，上药益药医药（上海）有限公司成立，法定代表人为顾斌，注册资本为8亿元，经营范围包含：第一类医疗设备租赁；机械设备租赁；仓储设备租赁服务；数字创意产品展览展示服务等。企查查股权穿透显示，该公司由上海医药（601607）全资子公司上药控股有限公司、上海医药大健康云商股份有限公司共同持股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606083763482714.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159938","09939","BK1574","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641411787","title":"大型医药股表现活跃，指数逆势收涨，医药ETF易方达（512010）本周“吸金”超8亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2641411787","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641411787?lang=zh_cn&edition=full","pubTime":"2026-06-05 19:13","pubTimestamp":1780658013,"startTime":"0","endTime":"0","summary":"截至收盘，沪深300医药卫生指数上涨0.8%，中证生物科技主题指数上涨0.1%，中证创新药产业指数下跌0.02%，中证港股通医药卫生综合指数下跌0.8%，恒生港股通创新药指数下跌1.5%。Wind数据显示，医药ETF易方达(512010，联接基金A/C：001344/007883)本周前四个交易日连续获资金净流入，合计超8亿元。中信建投研报表示，医疗器械行业将迎来业绩修复和估值重塑。中国器械企业龙头持续创新、出海、并购，有望成长为全球医疗器械龙头，行业成长逻辑已从国产替代拓展到国际化和技术创新，估值迎来重塑机遇。⁠","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026060500035074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK1161","09939","BK1574","BK1515","512010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641115053","title":"6月5日悦康药业跌15.77%，富国医药创新股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641115053","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641115053?lang=zh_cn&edition=full","pubTime":"2026-06-05 16:38","pubTimestamp":1780648713,"startTime":"0","endTime":"0","summary":"证券之星消息，6月5日悦康药业跌15.77%创60日新低，收盘报13.73元，换手率8.54%，成交量38.41万手，成交额5.46亿元。重仓悦康药业的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共7家，其中持有数量最多的公募基金为富国基金的富国医药创新股票A。富国医药创新股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500028298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688658","BK1515","BK0239","BK1574","159938","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640815443","title":"创胜集团医药-B(06628)建议委任徐汉森为非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2640815443","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640815443?lang=zh_cn&edition=full","pubTime":"2026-06-04 19:21","pubTimestamp":1780572110,"startTime":"0","endTime":"0","summary":"智通财经APP讯，创胜集团医药-B 发布公告，徐汉森博士(徐博士)将获委任为非执行董事;及包骏博士(包博士)将获委任为独立非执行董事，惟均须待本公司股东于将于2026年6月30日召开的股东周年大会上批准后，方可作实。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450290.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","06628","159938","BK1515","BK1574","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640153649","title":"差异化创新破局，科望医药领航免疫治疗新蓝海","url":"https://stock-news.laohu8.com/highlight/detail?id=2640153649","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640153649?lang=zh_cn&edition=full","pubTime":"2026-06-04 16:41","pubTimestamp":1780562506,"startTime":"0","endTime":"0","summary":"当行业竞相追逐成熟靶点时，科望医药选择了更具挑战的源头创新之路，瞄准下一代免疫疗法，成为全球MCE赛道为数不多的定义者与领跑者。","market":"us","thumbnail":"https://img2.gelonghui.com/d273d-c4393547-47e6-485a-a81d-c0fea64e5b84.jpg?guru_height=855&guru_width=1280&guru_size=118253","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/d273d-c4393547-47e6-485a-a81d-c0fea64e5b84.jpg?guru_height=855&guru_width=1280&guru_size=118253"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/5064974","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1161","09939","BK1515","159938","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640587161","title":"楚天科技：将楚天打造成世界医药领军企业之一","url":"https://stock-news.laohu8.com/highlight/detail?id=2640587161","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640587161?lang=zh_cn&edition=full","pubTime":"2026-06-04 16:24","pubTimestamp":1780561450,"startTime":"0","endTime":"0","summary":"证券之星消息，楚天科技(300358)06月04日在投资者关系平台上答复投资者关心的问题。投资者提问：公司在多次访谈中提到'十五五'期间向百亿级企业迈进，请问公司十五五的总体目标是什么？有没有具体的量化目标？谢谢。楚天科技回复：您好！总体目标系将楚天打造成世界医药领军企业之一，谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400027690.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","159938","BK1161","BK1515","BK0028","BK1574","300358","09939","BK0251","BK0061"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kintor.com.cn","stockEarnings":[{"period":"1week","weight":-0.0958},{"period":"1month","weight":-0.1777},{"period":"3month","weight":-0.4085},{"period":"6month","weight":0.1919},{"period":"1year","weight":0.4048},{"period":"ytd","weight":0.2041}],"compareEarnings":[{"period":"1week","weight":-0.0398},{"period":"1month","weight":-0.0797},{"period":"3month","weight":-0.0478},{"period":"6month","weight":-0.0665},{"period":"1year","weight":-0.0048},{"period":"ytd","weight":-0.0539}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"开拓药业有限公司是一家主要从事创新药产品研发的投资控股公司。该公司产品致力于解决未满足临床需求的疾病领域，管线主要涵盖皮科（如脱发、痤疮等）及肿瘤适应症。该公司在皮科领域有两款核心药物KX-826及GT20029。该公司在其他疾病领域包括转移性去势抗性前列腺癌（mCRPC）、肝癌、特发性肺纤维化、恶性血液疾病及多种实体瘤等。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.020286},{"month":2,"riseRate":0.666667,"avgChangeRate":0.174983},{"month":3,"riseRate":0.333333,"avgChangeRate":0.058562},{"month":4,"riseRate":0.666667,"avgChangeRate":0.374359},{"month":5,"riseRate":0.5,"avgChangeRate":0.006013},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.053593},{"month":7,"riseRate":0.666667,"avgChangeRate":0.132768},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.071497},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.129033},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.103242},{"month":11,"riseRate":0.666667,"avgChangeRate":0.073526},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.185801}],"exchange":"SEHK","name":"开拓药业-B","nameEN":"KINTOR PHARMA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"开拓药业-B(09939)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供开拓药业-B(09939)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"开拓药业-B,09939,开拓药业-B股票,开拓药业-B股票老虎,开拓药业-B股票老虎国际,开拓药业-B行情,开拓药业-B股票行情,开拓药业-B股价,开拓药业-B股市,开拓药业-B股票价格,开拓药业-B股票交易,开拓药业-B股票购买,开拓药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"开拓药业-B(09939)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供开拓药业-B(09939)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}